(18.233.111.242)
Users online: 4145    [ij] [ij] [ij] 
Email id
 

Research Journal of Pharmacy and Technology
Year : 2015, Volume : 8, Issue : 12
First page : ( 1653) Last page : ( 1661)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2015.00298.X

Development and Validation of Novel RP-HPLC Method for Estimation of Bosentan in Pharmaceutical Dosage Forms

Koushik Oruganti Sai, Himaja V., Babu P. Srinivasa, Karthikeyan Ramadoss*

Vignan Pharmacy College, Vadlamudi-522213, Andhra Pradesh, India

*Corresponding Author E-mail: rkcognosy@gmail.com

Online published on 1 January, 2016.

Abstract

The aim of the present work was to develop and validate a simple, economical, efficient and method for the analysis of Bosentan in pharmaceutical dosage forms by reverse phase high pressure liquid chromatography. A Welchrom C-18 reverse phase column (4.6 x 250 mm, 5 μm). With mobile phase containing 10mM Phosphate Buffer (pH 6.0): Acetonitrile (50: 50, v/v) is used and eluents were monitored at 226nm. The retention time of Bosentan was 3.687min. The method showed a good linearity in the concentration range of 15–27 μg/mL. The validation characteristics included specificity, linearity and limit of detection, limit of quantification, precision, robustness and stability. Validation acceptance criteria were met in all cases. The percent recoveries ranged between 90.7–100 and RSD 0.28%. The method could be successfully used for the analysis of Bosentan in pharmaceutical dosage forms

Top

Keywords

Bosentan, RP-HPLC, Method development and Validation.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
436,511,537 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.